Terms ending in 2030
Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,682,979 | Substituted Pyrazolo [1,5-a] Pyrimidine Compounds as TRK Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 9,782,415 | Substituted Pyrazolo[1,5-a]pyrimidine Compounds as TRK Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 9,796,724 | Substituted Pyrazolo[1,5-a]pyrimidine Compounds as TRK Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 10,251,889 | SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS In force · Medium confidence | Array Biopharma Inc. | In force | Medium confidence | |
| US 10,758,542 | SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 8,063,050 | Hydroxylated and Methoxylated Pyrimidyl Cyclopentanes as Akt Protein Kinase Inhibitors In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 8,853,216 | Hydroxylated Pyrimidyl Cyclopentane as Akt Protein Kinase Inhibitor In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 8,618,097 | Pyrimidyl Cyclopentanes as Akt Protein Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 9,593,099 | Compounds and Compositions as Protein Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 9,593,100 | Compounds and Compositions as Protein Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| 7 more term ends in 2030 · Pro | |||||
10 of 17 patents shown. Soonest term end first, then patent number.
Pro members see all 17.
15 of these are in force and held by Array Biopharma Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.